ARCHIVES

Over Half of ALK-Positive NSCLC Patients Responded To Crizotinib In Colorado Study

This article is from The Cancer Letter archive.

Vol. 33 No. 11 | November 26, 2010

Download PDF Visit The Full Archive

Related Articles

How to Become a Urology Millionaire…Alas, One Little Problem—Overtreatment

April 13, 2012

NCI-Approved Clinical Trials

July 30, 2004

In Brief: Chance for Rauscher Pay Increase Bill Seems Diminishing, But Schmidt Remains Confident

April 30, 1976

Shared Decisionmaking Called For In PSA Screening For Ages 55-69

May 31, 2013

Paulette Gray named director of NCI Division of Extramural Activities.

April 22, 2005

DePinho’s Handling Of MD Anderson Tenure Dispute Triggers Formal Investigation by AAUP

July 18, 2014